Tissue Regenix Group (TRX)

Sector:

Financials

Index:

FTSE AIM All-Share

 7.25p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 7.25
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 71.40m
  • Volume: 0
  • Market Cap: £5.18m
  • RiskGrade: 22

TRX Overview

Tissue Regenix Group is in the financials sector and is currently trading at 7.25p per share. In the last year Tissue Regenix Group's share price has ranged from 7.25p to 7.25p.

Key Personnel

CEO: Daniel Lee
CFO: Kirsten Lund
Executive Chairman: Jay LeCoque
Independent Non-Executive Director: Brian Phillips
Independent Non-Executive Director: Trevor Phillips
Interim CFO: Brandon Largent
Non-Executive Chairman: Jonathan Glenn
Non-Executive Dir: Shervanthi Homer - Vanniasinkam

Contact Details

Address: Unit 3, Phoenix Court, Lotherton Way, Garforth, United Kingdom, LS25 2GY
Phone: +44 (0) 1904 567 609
Fax: +44 (0) 1904 380 517
Website: http://www.tissueregenix.com/

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BNTXR104

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

TRX Market Data

Currency UK Pounds
Share Price 7.25p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 7.25
52 Week Low 7.25
Volume 0
Shares Issued 71.40m
Market Cap £5.18m
RiskGrade 22

TRX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.86% below the market average6.86% below the market average6.86% below the market average6.86% below the market average6.86% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Value
6.86% below the market average6.86% below the market average6.86% below the market average6.86% below the market average6.86% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Income Not Available
Growth
14.42% above the market average14.42% above the market average14.42% above the market average14.42% above the market average14.42% above the market average
3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average

TRX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

TRX Key Personnel

CFO Kirsten Lund
CEO Daniel Lee

Top of Page